MedTrace Logo

Cohort Study in Type 2 Diabetes in China

NCT01076023 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2013-02-15

No results posted yet for this study

Summary

This study is designed to assess the incidence of cardiovascular events occurred within an 12 month follow up period in type 2 diabetic patients with either high risk of cardiovascular disease (CVD) or history of coronary artery disease (CAD) or stroke.

Conditions

Sponsors & Collaborators

  • Roche Pharma AG

    collaborator INDUSTRY

  • VitalStrategic Research Institute

    collaborator OTHER

  • Chinese College of Cardiovascular Physicians

    collaborator UNKNOWN

  • Chinese Society of Endocrinology

    collaborator UNKNOWN

  • China Cardiometabolic Registries

    lead NETWORK

Principal Investigators

  • Guang Ning, MD · Shanghai JiaoTong University RuiJing Hospital

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2012-10-31
Completion
2013-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01076023 on ClinicalTrials.gov